Walter M. Stadler to Protease Inhibitors
This is a "connection" page, showing publications Walter M. Stadler has written about Protease Inhibitors.
Connection Strength
0.235
-
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study. J Clin Oncol. 2004 Jan 01; 22(1):115-9.
Score: 0.235
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.